UK Markets closed

Hofseth BioCare ASA (0Q6H.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
8.04+8.04 (-77.53%)
At close: 02:20PM GMT
Currency in NOK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 38.04
52-week low 38.04
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8153.82M
% held by insiders 152.53%
% held by institutions 120.35%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin -144.29%
Operating margin (ttm)-135.97%

Management effectiveness

Return on assets (ttm)-19.57%
Return on equity (ttm)-95.30%

Income statement

Revenue (ttm)96.35M
Revenue per share (ttm)0.27
Quarterly revenue growth (yoy)-16.80%
Gross profit (ttm)13.78M
EBITDA -115.74M
Net income avi to common (ttm)-139.03M
Diluted EPS (ttm)-0.31
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.69M
Total cash per share (mrq)0.02
Total debt (mrq)159.66M
Total debt/equity (mrq)204.97
Current ratio (mrq)0.89
Book value per share (mrq)0.74

Cash flow statement

Operating cash flow (ttm)-89.51M
Levered free cash flow (ttm)-72.48M